Congenital hypogonadotropic hypogonadism (CHH) is a rare disorder caused by the
deficient production, secretion or action of gonadotropin-releasing hormone (GnRH), which …

Purpose The concept of testosterone (T) supplementation (TS) as a new anti-obesity
medication in men with testosterone deficiency syndrome (TDS) is emerging. Data from …

1.1 ОПРЕДЕЛЕНИЕ ЗАБОЛЕВАНИЯ ИЛИ СОСТОЯНИЯ (ГРУППЫ ЗАБОЛЕВАНИЙ ИЛИ
СОСТОЯНИЙ) 7 1.2 ЭТИОЛОГИЯ И ПАТОГЕНЕЗ ЗАБОЛЕВАНИЯ ИЛИ СОСТОЯНИЯ …

ABSTRACT Introduction In 2014, the International Society for Sexual Medicine (ISSM)
convened a panel of experts to develop an evidence‐based process of care for the …

This narrative review presents an overview of current knowledge on fertility and reproductive
hormone changes in aging men, the factors driving and modulating these changes, their …

Several large cohort studies have disclosed the trajectories of sex steroids changes
overtime in men and their clinical significance. In men the slow, physiological decline of …

Several studies highlight that testosterone deficiency is associated with, and predicts, an
increased risk of developing metabolic disorders, and, on the other hand, is highly prevalent …

Obesity and male hypogonadism (HG) are often associated, as demonstrated in all cross-
sectional studies. Prospective studies have indicated that i) having HG at baseline increases …

Abstract Introduction: This article, Part 1 of the Endocrine Society of Australia's position
statement on male hypogonadism, focuses on assessment of male hypogonadism, including …

Testosterone (T) has a number of important effects on the cardiovascular system. In men, T
levels begin to decrease after age 40, and this decrease has been associated with an …